DBV Technologies (DBVT) Tax Rate (2020 - 2026)

Name: DBV Technologies (DBVT) Tax Rate (2020 - 2026) | Business Quant
Creator: Business Quant

DBV Technologies (DBVT) reported Tax Rate of 0.42% for Q1 2026, up 49.85% on a QoQ basis from 0.84% in Q4 2025.

DBV Technologies (DBVT) has 7 years of Tax Rate data on file, last reported at 0.42% in Q1 2026.

Quarterly Tax Rate changed N/A year-over-year to 0.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.41% (down 41.0% YoY) and the FY2025 annual result came in at 0.34%, down 29.0% from the prior year.
Tax Rate rose to 0.42% in Q1 2026 per DBVT's latest filing, from 0.84% in the prior quarter.
Across five years, Tax Rate topped out at 0.05% in Q4 2023 and bottomed at 0.84% in Q4 2025.
The 5-year median for Tax Rate is 0.18% (2024), against an average of 0.25%.
The widest annual swing landed in 2022, when Tax Rate grew 21 bps; it then slumped 81 bps in 2025.
Tracing DBVT's Tax Rate over 5 years: stood at 0.04% in 2022, then increased by 24 bps to 0.05% in 2023, then sank by 157 bps to 0.03% in 2024, then slumped by 2665 bps to 0.84% in 2025, then jumped by 50 bps to 0.42% in 2026.
Per Business Quant, the three latest DBVT Tax Rate figures stand at 0.42% (Q1 2026), 0.84% (Q4 2025), and 0.28% (Q2 2025).

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	57.14
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	5.61
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	17.68
7	Evaxion A	62.56 Bn	62.54 Bn	-	-6.79
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	12.51
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	7.07
10	DBV Technologies	8.00 Bn	7.77 Bn	-3.90 Mn	-0.42

Download Data 🔒